PushanRichardDasguptaMD, PhD

Neurooncology

Neuro-Oncology Fellow

Dr. Dasgupta is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

University of Texas M D Anderson Cancer CenterFellowship, Neuro-Oncology, 2023 - 2025
University of Texas at Austin Dell Medical School/Dell Seton Medical CenterResidency, Neurology, 2019 - 2023
McGovern Medical School at UTHealthClass of 2019
MD Anderson Cancer Center PhD, Genes and Development , 2013 - 2017
Harvard UniversityAB, Molecular and Cellular Biology and Mind/Brain/Behavior, 2006 - 2010

PubMed

23 citations
Medium-Chain Acyl-CoA Dehydrogenase Protects Mitochondria from Lipid Peroxidation in Glioblastoma
Francesca Puca, Fei Yu, Caterina Bartolacci, Piergiorgio Pettazzoni, Alessandro Carugo
Cancer Discovery. 2021-05-26
2 citations
Immunotherapy for Neuro-oncology.
Nazanin K Majd, Pushan R Dasgupta, John F de Groot
Advances in Experimental Medicine and Biology. 2021-01-01
11 citations
Immunotherapy for Neuro-Oncology.
Nazanin Majd, Pushan Dasgupta, John de Groot
Advances in Experimental Medicine and Biology. 2020-01-01

Journal Articles

An incidental finding of a high-grade glioma with pleomorphic and pseudopapillary features (HPAP) with PBRM1 mutation
Maria A Gubbiotti, MD, PhD, Jeffrey S Weinberg, MD, Shiao-Pei Weathers, MD, Pushan Dasgupta, MD, PhD, Martin C Tom, MD, Kenneth Aldape, MD, PhD, Martha Quezado, MD, Zi..., Journal of Neuropathology & Experimental Neurology, 1/2/2024
A complement to the H-index: a metric based on primary authorship
Pushan Dasgupta, Heinrich Taegtmeyer, The American Journal of Medicine